Dualyx
PrivateLast Round
Series A
May 15, 2023
Total Funding Raised
$51.7M
Company Overview
Dualyx operates in Healthcare & Life Sciences and is based in Belgium. Its latest recorded funding round was a Series A round in May 2023.
Dualyx is a biotechnology company that develops next-generation immune modulators and Treg-based therapies for autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dualyx Comparables
Compare Dualyx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TRexBio | 81% | |
| Egle Therapeutics | 79% | |
| Mozart Therapeutics | 78% |
For institutional investors. Book with your work email.
Dualyx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 15, 2023 | ||||
| Seed | Mar 1, 2020 |
For institutional investors. Book with your work email.
Dualyx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion | Series A |
| Andera Partners | Series A |
| Fountain Healthcare Partners | Series A |
| V-Bio Ventures | Seed, Series A |
| PMV | Seed, Series A |
| BioGeneration Ventures | Seed, Series A |
| Bgvcat | Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2020
$8M raised from BioGeneration Ventures and others.
For institutional investors. Book with your work email.
Dualyx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dualyx's valuation, stock price, and market status.
Is Dualyx a public or private company?
Dualyx is a private company.
What is the current stock price of Dualyx?
Dualyx is a private company, so its shares have no public market price. Caplight tracks Dualyx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dualyx worth (valuation)?
Valuation information for Dualyx is not publicly available.
Can I buy Dualyx stock?
Dualyx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dualyx's last funding round?
Dualyx's most recent funding round was Series A on May 15, 2023.
Who are the main investors in Dualyx?
Key investors in Dualyx include Forbion, Andera Partners, Fountain Healthcare Partners.
Will Dualyx IPO soon?
No public IPO plans have been announced for Dualyx.
How can I track Dualyx secondary market activity?
Caplight tracks bids, offers, and trades in Dualyx's shares on secondary markets.